INDUSTRY
GLP-1 & Obesity
The GLP-1 obesity-drug leaders and the challengers chasing the market — one of the largest new pharmaceutical categories in a generation, spanning the incumbents with approved drugs and the biotechs racing next-generation candidates. Clinical and regulatory milestones drive the group. The Soar engine grades the basket for setups.
Track Record
Live engine results
Live engine results.These are the Soar engine’s real, resolved signals on this basket’s tickers — actual performance, not a simulation.
59%Win rate
10wins·7losses
18 resolved all-time
36.0%–78.4% 95% CI
36.0%–78.4% 95% CI
Equity curve+5.9%
Indexed to 100 · 10-position book · 10% per trade · illustrative
Stats by window
Closed
17
10W · 7L
Win Rate
58.8%
36.0%–78.4% CI
Avg P&L
+2.89%
+2.55% median
Profit Factor
4.58
+2.89% exp.
Best Win
+14.1%
Worst Loss
-2.6%
Max Drawdown
9.0%
all-time
Avg Hold
7.1 days
Outcome mix
Target 2528%
Target 1211%
Stop after T1317%
Stopped out739%
Expired16%
P&L distribution
7
4
4
2
≤-20%0%≥+20%
By timeframe
NWinAvg
1457%+2.5%
367%+4.9%
By asset class
NWinAvg
1759%+2.9%
These are real, liveSoar engine results on this basket’s tickers — each card’s entry, targets, and stop measured against where price actually went. Win rate counts a Target 1 or Target 2 hit as a win and a stop as a loss; expired signals are excluded. The equity curve sums each signal’s return at a 10-position book · 10% per trade · illustrative. Past performance does not guarantee future results.
Basket Constituents
21 tickers in this basket
The curated set of tickers the Soar engine scans for this strategy. Signals appear here when the engine finds a setup on one of them — this list itself is not a signal to buy.
This basket is curated by Soar — a fixed set of tickers representing the industry. The Soar engine scans these names on its regular schedule and publishes a signal here when it finds a setup. The basket itself is informational, not a recommendation to buy.
Recent Signals
Last 11 signals
About this strategy
Why it matters
GLP-1 obesity drugs are reshaping healthcare and represent one of the biggest new drug markets in decades. Trial readouts and approvals are major catalysts across the group.
Disclosure: Soar publishes analysis from this source. We do not endorse, recommend, or advise on any trade. Past performance does not guarantee future results. All signals are educational; do your own research before acting.
Self-host your bot and your broker keys never touch Soar's servers; choose Soar-managed and they're stored encrypted and scoped to trade-only. Either way, Soar can never move your funds — bots execute directly against your own broker connection.